Yüklüyor......
A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
AIM: To evaluate the efficacy and safety of entecavir (ETV) in hepatitis Be antigen (HBeAg)-positive chronic hepatitis B (CHB) patients who had not received a nucleoside analogue and who had failed in lamivudine (LVD) therapy. METHODS: Sixty-one patients were divided into three groups. Forty-two pat...
Kaydedildi:
| Yayımlandı: | World J Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Co., Limited
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4250629/ https://ncbi.nlm.nih.gov/pubmed/17696259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i31.4264 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|